Curative Biotechnology Inc (ID)【CUBT】株式ニュース

個人投資家向けのプロ仕様のツール。

プレミアム

Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement

PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary...

Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy

Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical Study Palm...

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23...

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23...

Curative Biotechnology Announces Canadian Patent Allowance

“Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE...

Form RW - Registration Withdrawal Request

Curative Biotechnology, Inc. Announces Letter to Shareholders

Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form S-1 - General form for registration of securities under the Securities Act of 1933

Securities Registration Statement (s-1/a)

0001400271 true

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for...

trader59 11時間前

CUBT I really can't say too much on a public message board nor am I am insider, but what I will say is the impression that I have received from the people I talk to within the 'circle of trust' for CUBT leads me to believe that this will be a potential billion dollar bio company if it is not bought out before then.

LOL. Now that's some spin-dancing there...

"A potential billion dollar bio company" that owns nothing other than some licenses on some "orphaned" (ie - abandoned by their original developer due to unprofitability) that they haven't done any sort of substantial R&D on since 2022...

https://www.otcmarkets.com/stock/CUBT/financials

👍️0

Threeflight 12時間前

CUBT I really can't say too much on a public message board nor am I am insider, but what I will say is the impression that I have received from the people I talk to within the 'circle of trust' for CUBT leads me to believe that this will be a potential billion dollar bio company if it is not bought out before then.

I have no real reason to doubt them. The last time I felt this good about CUBT was when it was at 007 and went to .25. I think this time, again with the caveat that everything comes together, that run could be childs play compared to what is coming.

Just look how this trades. Imagine they come out with a financing/collab/M&A PR. With this OS? It goes to $50. Probably much more. And imo it is coming.

👍️ 1

Wrangler1 19時間前

Please tell us more about the merit. One day remaining this week. It’s time these guys actually get something accomplished.

👍️ 1

Threeflight 6日前

IMO CUBT starts to make a major move to the upside in the next week or so. Just my opinion but I don't say that without merit.

1. The Global "Bharti" Platform License (PCT/US2020/050540)The foundation of Curative's intellectual property is its exclusive, worldwide license from the National Eye Institute (NEI) for the fundamental discovery titled "Druggable Targets to Treat Retinal Degeneration".International Phase Status: This core invention was processed through an international PCT application, allowing the technology to seek parallel protection across over 150 contracting member countries.National Phase Entry: The recent Canadian patent allowance represents a successful breakthrough from this international pipeline. The underlying application claims priority to the original U.S. filings, enabling Curative to advance national-phase examinations simultaneously within the European Patent Office (EPO) and key Asian markets.

👍️0

moczowy 1週前

Preclinical Benchwork Base: The company is bypassing early-stage exploratory K9 data by relying on extensive human preclinical research models. They are leveraging the FDA's Minor Uses in Major Species (MUMS) accelerated approval pathway, arguing that the existing human preclinical data provides the "reasonable expectation of effectiveness" required to start an abbreviated 24-dog conditional trial directly.

👍️ 1

Threeflight 1週前

CUBT. Get ready for a filing which imo takes it to $10 and more. Depending on the BIO stock mania.

👍️0

Threeflight 1週前

OTCID for CUBT today. Next step financing. Next step Nasdaq.

👍️0

Threeflight 1週前

Yeah something is happening. Quote wasn't showing up on my streamer (fidelity) initially (it is now) and OTCID now as well. Very positive.

CUBT nice article. I believe this is similar to what Curative is about to embark on but with more added capital to start. Standing by for the coming PR.

👍️0

moczowy 2週前

https://www.lifescienceleader.com/doc/why-drug-repurposing-might-be-biotech-s-most-capital-efficient-strategy-0001

👍️0

My911Voice 2週前

We were supposed to have lit this rocket, right?

Feels like an Acme special.

😂 1

Gonzal 3週前

Finally CUBT and *MEDH about to lift off!!

Which one first!

👍️0

conix 4週前

CUBT chart is looking good for a change. I noticed the 10K bid too.

👍️0

Threeflight 4週前

CUBT I am in Vegas for the weekend and missed the last part of trading today traveling. Did the ask get heavy at all? Nice close regardless. Did you notice that 10 K bid earlier in the morning? Good to see.

👍️0

Stock_Barber 4週前

Whatever the origin of the trades, it is following a pattern of OTC stocks that explode... one that we have both certainly seen many times.

I am invariably the one, like you, warning others away at it goes 10-50 fold.

I have a few bucks here, and I'll let it ride.

I have seen 3Flight hit a home run before...

🔥 1 🚀 1

trader59 4週前

Somebody's playing with the PPS. 13 trades so far, over a 4 to 1 sell to buy ratio, yet the PPS is up. As I said, creating an illusion of interest in the stock.

I don't think anyone has claimed otherwise? Not sure why you are making a big deal out of a low float/OS stock gradually rising. All he said was the stock is starting to move. Which it is.

I mean it is better than gradually falling amirite?

All I have said is with the low float and OS. And CUBT being a bio? I have seen 1000, 10,000, even 50,000 percent moves with stocks like this. Will it happen?

Who knows. But signs are definitely starting to point in the positive direction.

But go ahead. Poo poo.

👍️0

trader59 4週前

And, once again, 15 trades all day long, 3200 shares. That's it, and hardly any money involved.

👍️0

Threeflight 4週前

Yes. I am sure there are people out there in the Universe that are spending their hard earned dollars on CUBT to slowly and gradually take it up...all for the fun of it. Not for any other valid reason. Just......reasons.

I don't mind a hater. They are actually good for stocks to have. But you have CDS. Curative Derangement Syndrome.

👍️0

trader59 4週前

You can make an illiquid stock do whatever you want it to do, and the last 2 "VERY good" PR's were just fluff.

👍️0

Threeflight 4週前

I noticed that you didn't say a word about the last 2 VERY good PR's. But are super quick to poo poo the trading pattern of CUBT. Even though it is moving up.

👍️0

trader59 4週前

Yeah, I did. Sorry about that.

👍️ 1

Threeflight 4週前

Yeah he was talking about me. But in my defense, I think I have a really good track record when it comes to CUBT.

I pumped it back in 2020 and it went from .007 to 23 cents. That is great by any measure.

I bashed the hell out of it in 2023 or so and in the next 2 years it went back down to .004 because I had a 'feeling' it was in a dead zone because of interest rates, new OTC rule changes, and financing for OTC companies went totally dry. It was a no win situation.

I am now VERY positive on CUBT because one...we have a new Sec of Health in charge who loves companies like CUBT. Two...because interest rates are falling or are predicted to fall. Three....because financing for LEGIT OTC companies like CUBT is loosening up. And four....because I think CUBT has a drug port that if successful is now worth multi billions and they are much closer to getting that developed than they ever have been. The US and western world population is aging. Aging means eye issues. CUBT has a potential treatment for that. The dog and pet angle is icing on the cake.

So far from my .004 call it has gone to almost .01 pre RS. Not huge. But ok. I think with the small OS and float (which is why I loved the RS considering it is a bio tech)....if the right things happen? This is a $100 a share stock or more if bio tech/short/drug port mania hits it.

👍️ 1

Stock_Barber 4週前

You clearly have me confused with someone else...
He's been claiming to know stuff that wasn't or hasn't come true for quite some time.

💯 1

Threeflight 4週前

To put this into perspective, the stock is still only really trading at around .009 pre RS. This stock has a lonnnnnngggg way to go to the upside to get back to even close to old highs. Which, if they come through this time on their drug portfolio, should be surpassed easily.

I know that is an IF, but if's and CUBT investment gluts were candy and nuts, oh what a Merry Christmas we would have.

👍️0

Threeflight 4週前

Ya never know. But the ask has really thinned out and the bids are growing. Which is always a good sign.

👍️0

govprs 4週前

I didn’t take that persons post in the same way but now understand better your perspective
I always appreciate your counter views just not on this one specifically.

👍️0

trader59 4週前

That comment was for perspective, or maybe counter perspective. One poster thinks that 15 trades with a PPS increase on an OTC stock in a whole trading day is significant, adding in the standard "somebody knows something" narrative. He's been claiming to know stuff that wasn't or hasn't come true for quite some time. It earned a counter perspective.

👎️ 1

govprs 4週前

I’ve always appreciated your factual comments with filings etc but this particular comment adds no value to anyone

🎯 1 👍️ 1

trader59 4週前

15 trades all day long, total of 3200 shares washed around to create an illusion of interest in this stock so you'd have something to pump.

👍️0

Stock_Barber 4週前

Definitely starting to move!

News leaking?

👍️0

Eagle1 1月前

Yes sir, 100% agree!

I like where this is heading and as we all know these things take longer than expected almost always.

Love the fact that the management didn't do an extreme RS but the initial range they put out really was unnecessary. Whomever did that, shame on them LOL.

I love Paul, he is awesome!

👍️0

Threeflight 1月前

CUBT I "think" the next news event we get is going to be financing. It makes sense considering the last 2 PRs. In which case off to the races.

👍️ 3 💯 1

Threeflight 1月前

CUBT nice day. Just wait until the real volume comes in when financing is announced. Which seems obvious to me that news about it is imminent. This could be one of those bio stocks you see that goes up $50 in a day.

Liftoff time is coming.

👍️ 2

moczowy 1月前

And the news came from Taiwan

👍️0

Threeflight 1月前

CUBT nice bio news today-this is a multi $billion market and 2 things are obvious to me. One, their drug pipeline is legit as they are starting to partner with multiple entities to develop their eye drug pipeline. And two, CUBT is ramping up their R & D and is getting ready to begin trials in this space. If so, this is easily a $billion or multi $billion company.

https://www.otcmarkets.com/stock/CUBT/news/Curative-Biotechnology-Advances-Translational-Ophthalmology-Program-Through-PennVet-Research-Agreement?id=520425

👍️0

moczowy 1月前

Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement | Taiwan News | May. 7, 2026 19:00 https://share.google/85LN2PHGyHZol0AoT

👍️0

Threeflight 1月前

Getting ready for the right way. It is very near. All IMO :).

59,000-70,000 deaths per year annually.

👍️ 1

pzottkpz 2月前

🎻 none taken ☀️
💲🌾 🌾🌾🌾🌾🌾🌾🌾🌾🌾🌾💲

👍️ 1

Stock_Barber 2月前

Sorry for giving you attitude, so many drive-by bashers these days, it is hard to separate the wheat from the chaff!

😁

👍️0

pzottkpz 2月前

Mooochas grazie for esplanin SB
🐶🦴DD

👍️0

Stock_Barber 2月前

HINT - That is rabies in HUMANS, not dogs!

If the facts matter... do they?

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Curative Biotechnology Inc (ID) (CUBT)

個人投資家向けのプロ仕様のツール。

Curative Biotechnology Inc (ID) (CUBT) ニュース

Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement

Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Curative Biotechnology Announces Canadian Patent Allowance

Form RW - Registration Withdrawal Request

Curative Biotechnology, Inc. Announces Letter to Shareholders

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form S-1 - General form for registration of securities under the Securities Act of 1933

Securities Registration Statement (s-1/a)

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

CUBT Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Curative Biotechnology Inc (ID) (CUBT)

個人投資家向けのプロ仕様のツール。

Curative Biotechnology Inc (ID) (CUBT) ニュース

Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement

Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Curative Biotechnology Announces Canadian Patent Allowance

Form RW - Registration Withdrawal Request

Curative Biotechnology, Inc. Announces Letter to Shareholders

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form S-1 - General form for registration of securities under the Securities Act of 1933

Securities Registration Statement (s-1/a)

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

CUBT Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する